Abstract:Highlights • This study highlights the benefits of integrating microneedle (MN) technologies with the nanoemulsion (NE) system represents a promising approach to enhance the transdermal delivery of estradiol valerate (E2V), a hydrophobic drug with a Log P of 6.62. • E2V-NE formulations and core-shell dissolving microneedles (CS-dMNs) were developed utilizing a computational design strategy. • Developed self-administered E2V-NE-loaded CS-dMNs offering a convenient platform for achieving long-acting and controlled hormone levels in clinical response dosages. Estradiol valerate (E2V) is a hormone utilized for estrogen replacement therapy. Nonetheless, its application in pharmaceutical formulations has been limited due to its poor solubility in water and suboptimal efficacy for transdermal drug delivery. Hence, the combination of nanoemulsions (NEs) with core-shell dissolving microneedles (CS-dMNs), which encase the drug, represents a promising approach to enhance transdermal drug delivery while ensuring controlled release. This study aimed to develop E2V-NE-loaded CS-dMNs for achieving controlled transdermal release of E2V. The E2V-NEs were formulated and evaluated for parameters including droplet size, polydispersity index (PDI), and zeta potential. Subsequently, these E2V-NEs were integrated into the core of CS-dMNs. The physical and mechanical properties of E2V-NE-loaded CS-dMNs were evaluated, along with parameters such as detachment time, drug content, in vitro and in vivo skin permeation, and safety. The results indicated that E2V-NE-loaded CS-dMNs exhibited favorable physical and mechanical characteristics, enabling easy self-administration with patch detachment after 30 min, while ensuring controlled drug release from the core of dMNs. The E2V content in CS-dMNs was determined to be 0.76 ± 0.15 mg/patch. Furthermore, in vitro and in vivo skin permeation studies demonstrated a synergistic effect between NEs and MNs, achieving therapeutic drug levels sustained over a week (368.54 ± 67.93 μg/mL in in vitro and 697.45 ± 270.10 pg/mL in in vivo), with no indications of infection and complete skin healing observed within 8 h. Consequently, E2V-NE-loaded CS-dMNs present a promising alternative for achieving sustained and controlled hormone levels conveniently. Graphical abstract Download : Download high-res image (242KB) Download : Download full-size image

Development and optimization of nanoemulsion containing exemestane using box-behnken design

Lyophilized mixed micelles of exemestane: A novel paradigm to improve its absorption and anticancer activity

Nanoemulsion‐based transdermal delivery of third‐generation steroidal and non‐steroidal aromatase inhibitors in preclinical models

Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies

A comprehensive review on novel delivery approaches for exemestane

Tamoxifen Citrate Containing Topical Nanoemulgel Prepared by Ultrasonication Technique: Formulation Design and In Vitro Evaluation

Development, Optimization and Evaluation of Emodin Loaded Nanoemulsion Prepared by Ultrasonic Emulsification

Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study

Poly(D, L-lactide-co-glycolide)/montmorillonite Nanoparticles for Improved Oral Delivery of Exemestane.

Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery

ENCAPSULATION OF EXEMESTANE WITH β-CYCLODEXTRIN AND TERNARY AGENT: FORMULATION, EVALUATION AND ANTICANCER ACTIVITY

Quality by Design Assisted Optimization and Risk Assessment of Black Cohosh Loaded Ethosomal Gel for Menopause: Investigating Different Formulation and Process Variables

Development and Optimization of Dipyridamole- and Roflumilast-Loaded Nanoemulsion and Nanoemulgel for Enhanced Skin Permeation: Formulation, Characterization, and In Vitro Assessment

Computer-aided design and optimization of estradiol valerate nanoemulsion-loaded core-shell microneedle patches for controlled release transdermal drug delivery

Formulation development of pharmaceutical nanoemulgel for transdermal delivery of feboxostat: Physical characterization and in vivo evaluation

QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies

Quality-by-design based fabrication of febuxostat-loaded nanoemulsion: Statistical optimization, characterizations, permeability, and bioavailability studies

Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal

Topical Delivery of Eberconazole Nitrate Loaded Microemulsion: Formulation, Design and Evaluation

Formulation Design, Preparation, and in Vitro and in Vivo Characterizations of Beta-Elemene-Loaded Nanostructured Lipid Carriers

In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties.